COM:BLUEBIRDBIO
bluebird bio
- Stock
Last Close
0.30
22/11 21:00
Market Cap
200.45M
Beta: -
Volume Today
10.33M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | -5.74M - | -258.81M 4,405.28% | -325.23M 25.66% | -147.02M 54.80% | -129.10M 12.19% | -54.96M 57.43% | 10.75M 119.56% | ||||
average payables | 3.66M - | 4.64M 27.01% | 10.00M 115.31% | 13.27M 32.70% | 15.35M 15.70% | 30.41M 98.10% | 32.30M 6.20% | 23.74M 26.49% | 25.49M 7.35% | 16.68M 34.55% | |
average receivables | 1.56M - | 8.52M 447.65% | 13.38M 57.00% | 19.82M 48.15% | 19.10M 3.63% | 11.09M 41.95% | 11.90M 7.31% | ||||
book value per share | 18.51 - | 24.53 32.56% | 23.32 4.94% | 37.29 59.91% | 36.23 2.85% | 23.28 35.73% | 21.79 6.40% | 5.43 75.08% | 2.50 54.00% | 1.77 29.10% | |
capex per share | -0.33 - | -0.20 37.97% | -0.43 110.82% | -1.43 233.26% | -1.07 25.07% | -1.38 28.98% | -0.47 66.26% | -0.33 28.39% | -0.17 49.65% | 0.08 149.07% | |
capex to depreciation | -2.06 - | -0.95 53.83% | -1.66 74.34% | -4.60 177.32% | -3.25 29.34% | -4.37 34.64% | -1.50 65.76% | -1.17 21.82% | -2.64 125.60% | 0.32 112.02% | |
capex to operating cash flow | 0.15 - | 0.07 50.87% | 0.08 17.67% | 0.22 163.05% | 0.13 39.23% | 0.14 0.21% | 0.06 54.39% | 0.04 41.28% | 0.04 3.41% | -0.04 202.97% | |
capex to revenue | -0.34 - | -0.50 46.28% | -2.60 418.60% | -1.76 32.39% | -1.02 41.87% | -1.71 67.14% | -0.12 93.23% | -6.28 5,333.64% | -3.67 41.54% | 0.31 108.36% | |
cash per share | 17.84 - | 14.94 16.25% | 18.89 26.46% | 29.63 56.86% | 26.62 10.16% | 20.05 24.70% | 18.52 7.64% | 4.35 76.53% | 2.29 47.20% | 2.02 12.01% | |
days of inventory on hand | -2.75K - | -208.74K 7,500.98% | -17.69K 91.53% | -10.13K 42.76% | -1.02K 89.94% | -51.22 94.97% | 249.51 587.17% | ||||
days payables outstanding | 3.08K - | 7.35K 139.00% | 5.27K 28.34% | 1.46K 72.27% | 243.13 83.36% | 908.86 273.82% | 201.38 77.84% | ||||
days sales outstanding | 32.06 - | 93.16 190.57% | 104.79 12.48% | 39.03 62.75% | 1.14K 2,808.16% | 1.09K 3.57% | 160.98 85.29% | ||||
debt to assets | 0.04 - | 0.09 110.19% | 0.15 76.59% | 0.08 46.18% | 0.07 15.84% | 0.11 60.25% | 0.11 1.99% | 0.15 39.22% | 0.51 236.12% | ||
debt to equity | 0.05 - | 0.10 118.58% | 0.20 92.70% | 0.10 51.01% | 0.08 14.46% | 0.15 81.06% | 0.14 4.16% | 0.24 68.03% | 1.43 498.76% | ||
dividend yield | |||||||||||
earnings yield | -0.03 - | -0.12 274.45% | -0.18 52.91% | -0.07 62.21% | -0.17 148.67% | -0.25 51.47% | -0.36 41.06% | -0.82 130.15% | -0.49 40.02% | -1.40 185.23% | |
enterprise value | 1.23B - | 1.34B 8.99% | 1.33B 0.63% | 4.42B 231.98% | 3.10B 29.96% | 3.00B 3.07% | 1.62B 46.09% | 616.83M 61.87% | 712.19M 15.46% | 260.13M 63.47% | |
enterprise value over ebitda | -20.44 - | -8.20 59.86% | -5.13 37.50% | -13.26 158.69% | -5.47 58.77% | -3.71 32.21% | -2.54 31.39% | -1.14 55.03% | -2.57 124.62% | -1.56 39.43% | |
ev to operating cash flow | -20.59 - | -13.61 33.90% | -7.02 48.42% | -15.75 124.41% | -7.49 52.47% | -5.32 28.99% | -3.44 35.31% | -0.97 71.78% | -2.02 107.93% | -1.11 45.15% | |
ev to sales | 48.35 - | 95.14 96.80% | 216.27 127.31% | 124.74 42.32% | 56.71 54.54% | 67.16 18.42% | 6.45 90.39% | 168.44 2,511.01% | 198.00 17.55% | 8.82 95.55% | |
free cash flow per share | -2.58 - | -3.04 18.08% | -5.52 81.28% | -7.87 42.76% | -9.02 14.51% | -11.61 28.73% | -8.03 30.81% | -9.56 19.02% | -4.66 51.25% | -2.22 52.30% | |
free cash flow yield | -0.04 - | -0.07 68.65% | -0.14 88.67% | -0.07 50.54% | -0.14 105.59% | -0.20 45.54% | -0.29 40.32% | -0.96 233.82% | -0.67 29.62% | -1.61 139.20% | |
graham net net | 15.37 - | 10.56 31.30% | 12.22 15.74% | 23.19 89.73% | 15.09 34.95% | 10.90 27.76% | 10.78 1.08% | 0.50 95.39% | -2.17 537.09% | -1.65 23.92% | |
graham number | 27.64 - | 51.53 86.43% | 60.90 18.17% | 80.43 32.08% | 93.30 16.00% | 86.57 7.21% | 69.85 19.32% | 31.59 54.78% | 13.81 56.28% | 8.77 36.50% | |
income quality | 1.23 - | 0.59 51.84% | 0.72 21.95% | 0.84 16.14% | 0.74 10.98% | 0.71 3.94% | 0.76 6.36% | 0.78 2.04% | 1.32 70.67% | 1.11 16.23% | |
intangibles to total assets | 0.07 - | 0.04 49.51% | 0.03 19.33% | 0.02 47.71% | 0.01 25.87% | 0.02 35.55% | 0.01 18.16% | 0.01 26.90% | 0.02 99.27% | 0.03 37.10% | |
interest coverage | -398.86 - | -106.25 73.36% | 166.00 - | -39.12 123.56% | -23.36 40.27% | 13.92 - | -14.94 207.34% | ||||
interest debt per share | 0.87 - | 2.54 193.14% | 4.57 79.86% | 3.53 22.67% | 3.26 7.86% | 4.09 25.66% | 3.10 24.11% | 1.30 58.12% | 3.32 155.24% | 0.15 95.51% | |
inventory turnover | -0.13 - | -0.00 98.68% | -0.02 1,079.98% | -0.04 74.69% | -0.36 893.55% | -7.13 1,890.01% | 1.46 120.53% | ||||
invested capital | 0.05 - | 0.10 118.58% | 0.20 92.70% | 0.10 51.01% | 0.08 14.46% | 0.15 81.06% | 0.14 4.16% | 0.24 68.03% | 1.43 498.76% | 364.70M 25,447,696,555.41% | |
market cap | 1.58B - | 1.44B 8.56% | 1.49B 3.33% | 5.02B 237.06% | 3.34B 33.43% | 3.14B 6.18% | 1.74B 44.45% | 688.41M 60.49% | 543.81M 21.01% | 151.56M 72.13% | |
net current asset value | 414.51M - | 372.12M 10.22% | 475.53M 27.79% | 1.34B 181.19% | 1.06B 20.64% | 709.74M 33.12% | 789.34M 11.22% | 117.00M 85.18% | -159.07M 235.96% | -142.94M 10.14% | |
net debt to ebitda | 5.78 - | 0.63 89.16% | 0.61 2.47% | 1.81 195.84% | 0.44 75.79% | 0.17 61.56% | 0.20 16.47% | 0.13 32.30% | -0.61 557.68% | -0.65 6.93% | |
net income per share | -1.83 - | -4.81 162.18% | -7.07 46.91% | -7.71 9.09% | -10.68 38.51% | -14.31 33.98% | -9.95 30.45% | -8.16 17.94% | -3.39 58.45% | -1.93 43.12% | |
operating cash flow per share | -2.25 - | -2.84 26.26% | -5.09 79.16% | -6.44 26.69% | -7.95 23.30% | -10.23 28.70% | -7.56 26.03% | -9.22 21.94% | -4.49 51.31% | -2.14 52.35% | |
payables turnover | 0.12 - | 0.05 58.16% | 0.07 39.55% | 0.25 260.64% | 1.50 501.00% | 0.40 73.25% | 1.81 351.31% | ||||
receivables turnover | 11.38 - | 3.92 65.58% | 3.48 11.10% | 9.35 168.47% | 0.32 96.56% | 0.33 3.71% | 2.27 579.98% | ||||
research and ddevelopement to revenue | 2.46 - | 9.52 286.77% | 33.27 249.46% | 7.71 76.83% | 8.22 6.64% | 13.04 58.62% | 2.34 82.01% | 87.37 3,625.86% | 66.93 23.39% | 5.68 91.51% | |
return on tangible assets | -0.09 - | -0.17 82.92% | -0.24 40.57% | -0.18 26.16% | -0.25 39.70% | -0.46 85.30% | -0.35 24.24% | -0.96 171.83% | -0.49 48.81% | -0.35 28.24% | |
revenue per share | 0.96 - | 0.41 57.59% | 0.17 59.35% | 0.81 392.94% | 1.05 28.90% | 0.81 22.83% | 4.03 398.18% | 0.05 98.68% | 0.05 13.87% | 0.27 486.78% | |
roe | -0.10 - | -0.20 97.78% | -0.30 54.55% | -0.21 31.78% | -0.29 42.56% | -0.61 108.48% | -0.46 25.70% | -1.50 229.24% | -1.36 9.68% | -1.09 19.77% | |
roic | -0.09 - | -0.17 78.33% | -0.23 36.08% | -0.17 25.44% | -0.26 51.80% | -0.49 86.71% | -0.36 25.65% | -1.07 195.11% | -0.38 64.58% | -1.25 231.66% | |
sales general and administrative to revenue | 0.91 - | 3.28 259.21% | 10.58 222.35% | 2.64 75.04% | 3.19 20.82% | ||||||
shareholders equity per share | 18.51 - | 24.53 32.56% | 23.32 4.94% | 37.29 59.91% | 36.23 2.85% | 23.28 35.73% | 21.79 6.40% | 5.43 75.08% | 2.50 54.00% | 1.77 29.10% | |
stock based compensation to revenue | 0.42 - | 2.92 589.83% | 6.46 121.15% | 1.50 76.72% | 2.03 35.02% | 3.60 77.06% | 0.62 82.63% | 34.93 5,491.63% | 9.78 71.99% | 0.66 93.27% | |
tangible asset value | 449.91M - | 812.91M 80.68% | 835.62M 2.79% | 1.59B 90.68% | 1.86B 16.66% | 1.26B 32.35% | 1.33B 5.91% | 368.63M 72.32% | 185.83M 49.59% | 178.45M 3.97% | |
tangible book value per share | 16.95 - | 23.45 38.35% | 22.41 4.42% | 36.60 63.30% | 35.72 2.39% | 22.79 36.22% | 21.42 5.99% | 5.35 75.03% | 2.36 55.80% | 1.62 31.29% | |
working capital | 437.01M - | 483.60M 10.66% | 649.68M 34.34% | 1.52B 133.76% | 1.27B 16.21% | 928.59M 27.03% | 1.01B 8.98% | 183.53M 81.86% | 71.25M 61.18% | 81.57M 14.49% |
All numbers in USD (except ratios and percentages)